Aytekin TOKMAK, İrfan ÖZER, Ali İrfan GÜZEL, Selçuk ERKILINÇ, Mahmut Kuntay KOKANALI, Mustafa UĞUR

Vaginal washing fluid C-reactive protein levels in women with recurrent or treatment resistant vaginitis

Amaç: Bu çalışmanın amacı tekrarlayan ve/veya tedaviye dirençli vajinit öyküsü olan olgularda vajinal yıkama sıvısı C-reaktif protein (CRP) düzeylerinin değerlendirilmesidir.Yöntemler: Bu prospektif vaka kontrollü çalışma hastanemizin jinekoloji kliniğinde yapılmıştır. Toplam 64 kadın (33 tekrarlayan ve/veya tedaviye dirençli vajinit öyküsü olan kadın çalışma grubu ve 31 sağlıklı kadın kontrol grubu) çalışmaya dâhil edilmiştir. Kaydedilen parametreler; yaş, başvuru şikâyeti, eğitim düzeyi, sosyoekonomik durum, vajinal duş (VD) sıklığı, periferik kan lökosit sayısı, vajinal sıvı CRP düzeyi, vajinal kültür, taze vajinal yayma ve idrar tetkikidir.Bulgular: Çalışma grubu istatistiksel olarak anlamlı düzeyde daha düşük eğitim düzeyi ve sosyoekonomik duruma sahipti (p

Tekrarlayan veya tedaviye dirençli vajinit olgularında vajinal yıkama sıvısında C-reaktif protein düzeyleri

Objective: The aim of this study is to evaluate the C-reactive protein (CRP) levels in vaginal washing fluid (VWF) in women with a history of recurrent and/or treatment resistant vaginitis.Methods: This prospective case control study was conducted in the gynecology clinic of the current hospital. A total of 64 women (33 with a history of recurrent and/or treatment resistant vaginitis as study group and 31 healthy women as control group) were enrolled in the study. The recorded parameters were; age, presenting symptom, educational level, socioeconomic status, frequency of vaginal douching (VD), peripheral blood leukocyte count, CRP levels in VWF, vaginal culture, fresh vaginal smear and urinalysis.Results: The study group had statistically significantly lower educational level and socioeconomic status than the control group (p

PDF

___

Ramírez SA, Pereiro MJ, Toribio J. Recurrent vulvovagi- nitis: diagnostic assessment and therapeutic manage- ment. Actas Dermo-Sifiliográficas 2008;99:190-198.
Sivaranjini R, Jaisankar T, Thappa D.M, et al. Spectrum of vaginal discharge in a tertiary care setting. Trop Parasi- tol 2013;3:135-139.
Guzel AI, Kuyumcuoglu U, Celik Y. Vaginal douching prac- tice and related symptoms in a rural area of Turkey. Arch Gynecol Obstet 2011;284:1153-1156.
Shaaban OM, Youssef AE, Khodry MM, et al. Vaginal douching by women with vulvovaginitis and relation to reproductive health hazards. BMC Women's Health 2013;13-23:1-6.
Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest 2003;111:1805-1812.
Ni CY, Jia WX, Yi WM, et al. Practicability of using vaginal fluid markers in detecting premature rupture of mem- branes. Ann Clin Biochem. 2003;40:542-545.
Torbé A, Czajka R. Are vaginal fluid procalcitonin levels useful for the prediction of subclinial infection in patients with preterm premature rupture of membranes? J Obstet Gynaecol Res 2005;31:464-470.
Celik Y. Biostatistics, principles of research.2nd edition. Di- yarbakir: Dicle University Press. 2007.
Pavlova S.I, Tao L. In vitro inhibition of commercial douche products against vaginal microflora. Infect Dis Obstet Gynecol 2000;8:99-104.
Brotman RM, Klebanoff MA, Nansel TR, et al. A longitu- dinal study of vaginal douching and bacterial vaginosis-a marginal structural modeling analysis. Am J Epidemiol 2008;168:188-196.
Sutton M, Sternberg M, Koumans EH, et al. The preva- lence of Trichomonas vaginalis infection among repro- ductive-age women in the United States, 2001-2004. Clin Infect Dis 2007;45:1319-1326.
Heng L.S, Yatsuya H, Morita S, et al. Vaginal douching in Cambodian women: its prevalence and association with vaginal candidiasis. J Epidemiol 2009;20:70-76.
Klebanoff MA, Nansel TR, Brotman RM, et al. Per- sonal hygienic behaviours and bacterial vaginosis. Sex Transm Dis 2010;37:94-99.
Eckert LO, Hawes SE, Stevens CE, et al. Vulvovaginal candidiasis: clinical manifestations, risk factors, man- agement algorithm. Obstet Gynecol 1998;92:757-765.
Corsello S, Spinillo A, Osnengo G, et al. An epidemio- logical survey of vulvovaginal candidiasis in Italy. Eur J Obstet Gynecol Reprod Biol 2003;110:66-72.
Seña AC, Bachmann LH, Hobbs MM. Persistent and re- current Trichomonas vaginalis infections: epidemiology, treatment and management considerations. Expert Rev Anti Infect Ther 2014;12:673-685.
Schwebke JR, Muzny CA, Josey WE. Role of Gardner- ella vaginalis in the Pathogenesis of Bacterial Vaginosis: A Conceptual Model. J Infect Dis 2014;[Epub ahead of print].
Hillier S.L, Nugent R.P, Eschenbach D.A, et al. Asso- ciation between bacterial vaginosis and preterm delivery of a low-birthweight infant. The Vaginal Infections and Prematurity Study Group. N Engl J Med 1995;333:1737- 1742.
Martin HL, Richardson BA, Nyange PM, et al. Vaginal lactobacilli, microbial flora, and risk of human immuno- deficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis 1999;180:1863-1868.
Wiesenfeld HC, Hillier SL, Krohn MA, et al. Bacterial vaginosis is a strong predictor of Neisseria gonorrhoe- ae and Chlamydia trachomatis infection. Clin Infect Dis 2003;36:663-668.
Vodstrcil LA, Hocking JS, Law M, et al. Hormonal con- traception is associated with a reduced risk of bacterial vaginosis: a systematic review and meta-analysis. PLoS One 2013;8:1-32.
Thompson D, Pepys MB, Wood SP. The physiological structure of human C-reactive protein and its complex with phosphocholine. Structure 1999;7:169-177.
Witkin S.S, Jeremias J, Ledger W.J. Recurrent vaginitis as a result of sexual transmission of IgE antibodies. Am J Obstet Gynecol 1988;159:32-36.
Nawrot U, Grzybek H.K, Zielska U, et al. The study of cell-mediated immune response in recurrent vulvovagi- nal candidiasis. FEMS Immunol Microbiol 2000;29:89-94.
Fidel PL. History and new insights into host de- fense against vaginal candidiasis. Trends Microbiol 2004;12:220-227.
Weissenbacher TM, Witkin SS, Gingelmaier A, et al. Relationship between recurrent vulvovaginal candidosis and immune mediators in vaginal fluid. Eur J Obstet Gy- necol Reprod Biol 2009;144:59-63.
Lev SA, Nyirjesy P, Tarangelo N, et al. Hyaluronan in vaginal secretions: association with recurrent vulvovagi- nal candidiasis. Am J Obstet Gynecol 2009;201:206.e1- 5.
Babula O, Lazdane G, Kroica J, et al. Relation between recurrent vulvovaginal candidiasis, vaginal concentra- tions of mannose-binding lectin and a mannose-binding lectin gene polymorphism in Latvian women. Clin Infect Dis 2003;37:733-737.
Babula O, Lazdane G, Kroica J, et al. Frequency of in- terleukin-4 (IL-4) -589 gene polymorphism and vaginal concentrations of IL-4, nitric oxide and mannose-binding lectin in women with recurrent vulvovaginal candidiasis. Clin Infect Dis 2005;40:1258-1262.